BillionToOne, Inc.
BLLN
Rank in Stocks
#3476
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Share Price
$105.11
Market Cap
$4.96B
Change (1 day)
1.56%
Change (1 year)
-
Country
US
Trade BillionToOne, Inc. (BLLN)
Category
Healthcare
Stock split history for BillionToOne, Inc. (BLLN)
BillionToOne, Inc. stock (symbol: BLLN) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 21, 2026.
One BLLN share bought prior to Oct 21, 2026 would equal to 0 BLLN shares today.
The most recent stock split occurred on Oct 21, 2026.
One BLLN share bought prior to Oct 21, 2026 would equal to 0 BLLN shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
